NASDAQ
Defence Therapeutics Inc. (DTCFF) has a free cash flow growth of -87.51% as of Friday, May 29, 2026. This represents a 63.66% increase compared to its 12-month average of -240.82%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.